Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation.
about
Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.Bloodstream infection following 217 consecutive systemic-enteric drained pancreas transplants.Sirolimus in pediatric renal transplantation.A comprehensive review of immunosuppression used for liver transplantation.Incidence and risk of treatment-related mortality with mTOR inhibitors everolimus and temsirolimus in cancer patients: a meta-analysisDefects in skin gamma delta T cell function contribute to delayed wound repair in rapamycin-treated miceSirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation.Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients.Calcineurin inhibitor minimization using sirolimus leads to improved renal function in pediatric heart transplant recipients.mTOR inhibitors in pediatric kidney transplantation.mTOR Inhibition by Everolimus Does Not Impair Closure of Punch Biopsy Wounds in Renal Transplant Patients.Mycophenolate mofetil: long-term outcomes in solid organ transplantation.Testosterone concentrations and sirolimus in male renal transplant patients.A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus.Rapamycin successfully treats post-transplant autoimmune hepatitis.Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus.Comparing the effect of isotopically labeled or structural analog internal standards on the performance of a LC-MS/MS method to determine ciclosporin A, everolimus, sirolimus and tacrolimus in whole blood.Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherence.Overview of Cellular Transplantation in Diabetes Mellitus: Focus on the Metabolic Outcome
P2860
Q24519078-6572E52E-4AEC-408E-9083-069E5832B154Q33253253-4991976C-5145-4D79-941B-275889EA866DQ33397668-D3AD11ED-B239-4525-A7DC-07F6D3B70DF0Q33602527-AE5075A9-8EB3-4693-9E86-4EBC56A66DB7Q34778631-F78E0811-1357-4BEA-899D-15ADC2201F4FQ36899362-8AE83AE1-A7B1-4FA8-BC11-347FDF4C0B48Q37001941-33286815-1B18-428F-88C8-DB8A011E62F0Q37355472-458C13F4-104B-4F7E-9FE6-AB4072703B43Q37924929-B156B89D-E7F5-452D-8EDC-F38EAD7C852AQ38112331-028B16D3-ED1B-4173-9C31-23EAE92F54B7Q38839083-21360CCA-A6BB-421F-B2A3-8CA680CD5BBBQ43061583-399F8D8A-F55E-421B-A47C-F2E00547E9B5Q44695059-FD64D589-BE9B-4BC7-BE89-A5DD47323C71Q45214571-A38198E1-5322-4236-9538-676D8DCE51ACQ46427150-808254BB-18AA-4FAD-BC7B-49D882527702Q46645995-44D86327-A43A-4A37-A623-B2F9F0CF37D8Q51725975-9F162FCD-3A50-4E87-AD9C-1CD53F5D1422Q53085840-8AF67FD7-B05F-4380-8E02-1C90F44E416AQ59101873-919BEB06-22C6-43B8-9D83-F243AAA1A72C
P2860
Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Rapamycin in combination with ...... s, and kidney transplantation.
@ast
Rapamycin in combination with ...... s, and kidney transplantation.
@en
type
label
Rapamycin in combination with ...... s, and kidney transplantation.
@ast
Rapamycin in combination with ...... s, and kidney transplantation.
@en
prefLabel
Rapamycin in combination with ...... s, and kidney transplantation.
@ast
Rapamycin in combination with ...... s, and kidney transplantation.
@en
P1476
Rapamycin in combination with ...... s, and kidney transplantation.
@en
P2093
MacDonald AS
P304
P356
10.1016/S0041-1345(03)00231-8
P407
P433
P577
2003-05-01T00:00:00Z